SCHEMBL7679543

SCHEMBL7679543

O=C(CC(C(=O)c1cccc(C(F)(F)F)c1)c1ccnc(F)c1)C1CCN(C(=O)OCc2ccccc2)CC1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
CYP2C19 P33261 1/20 0.42
GRIN2B Q13224 8/20 0.40
HTT P42858 1/20 0.40
FAAH O00519 1/20 0.39
HSD11B1 P28845 1/20 0.39
TRPV4 Q9HBA0 1/20 0.38
CYP2D6 P10635 3/20 0.38
CYP2C9 P11712 3/20 0.38
MGLL Q99685 1/20 0.37
CYP3A4 P08684 2/20 0.37
LNPEP Q9UIQ6 1/20 0.37
RBP4 P02753 1/20 0.37
GPR52 Q9Y2T5 1/20 0.37
CHRM2 P08172 1/20 0.37
CHRM4 P08173 1/20 0.37
CHRM3 P20309 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6950463 0.91 SMN1; SMN2 (0.46) SMN1; SMN2NPC1RAB9ACYP2C19GRIN2B
SCHEMBL7672577 0.86 SMN1; SMN2 (0.46) SMN1; SMN2NPC1RAB9ACYP2C19GRIN2B
SCHEMBL22589355 0.82 SMN1; SMN2 (0.49) SMN1; SMN2NPC1RAB9ACYP2C19GRIN2B
SCHEMBL7467972 0.80 SMN1; SMN2 (0.41) SMN1; SMN2NPC1RAB9ACYP2C19GRIN2B
SCHEMBL5725923 0.77 SMN1; SMN2 (0.51) SMN1; SMN2NPC1RAB9ACYP2C19GRIN2B
SCHEMBL5761752 0.77 SMN1; SMN2 (0.42) SMN1; SMN2NPC1RAB9ACYP2C19GRIN2B
SCHEMBL6189868 0.73 SMN1; SMN2 (0.44) SMN1; SMN2NPC1RAB9ACYP2C19GRIN2B
SCHEMBL5753131 0.73 SMN1; SMN2 (0.41) SMN1; SMN2NPC1RAB9ACYP2C19GRIN2B
SCHEMBL22589326 0.73 SMN1; SMN2 (0.46) SMN1; SMN2NPC1RAB9ACYP2C19GRIN2B
SCHEMBL22589283 0.73 CHRM2 (0.51) SMN1; SMN2NPC1RAB9ACYP2C19GRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6350744-B1 PYRMIDINE OR PYRIDINE DERIVATIVES; ANTIARTHRITIC AND ANTIINFLAMMATORY AGENTS; CACHEXIA TREATMENT; INTERLEUKIN AND TUMOR NECROSIS FACTOR INHIBITORS MERCK & CO., INC. 2002-02-26 US disclosed